EP3651731A4 - Pharyngeal or buccal cavity rinse and process of use thereof - Google Patents

Pharyngeal or buccal cavity rinse and process of use thereof Download PDF

Info

Publication number: EP3651731A4
Authority: EP; European Patent Office
Prior art keywords: pharyngeal; buccal cavity; cavity rinse; rinse; buccal
Prior art date: 2017-07-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP17917864.5A

Other languages

German (de)

French (fr)

Other versions

EP3651731A1 (en

Inventor

Jehangir Gowani

Ian Vonwald

Xiaojiang Wang

Evan BOYST

Shri Thanedar

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Gargle Water Inc

Original Assignee

Gargle Water Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-07-10

Filing date

2017-07-10

Publication date

2021-03-10

2017-07-10 Application filed by Gargle Water Inc filed Critical Gargle Water Inc

2020-05-20 Publication of EP3651731A1 publication Critical patent/EP3651731A1/en

2021-03-10 Publication of EP3651731A4 publication Critical patent/EP3651731A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP17917864.5A 2017-07-10 2017-07-10 Pharyngeal or buccal cavity rinse and process of use thereof Withdrawn EP3651731A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2017/041365 WO2019013750A1 (en)	2017-07-10	2017-07-10	Pharyngeal or buccal cavity rinse and process of use thereof

Publications (2)

Publication Number	Publication Date
EP3651731A1 EP3651731A1 (en)	2020-05-20
EP3651731A4 true EP3651731A4 (en)	2021-03-10

Family

ID=65002260

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP17917864.5A Withdrawn EP3651731A4 (en)	2017-07-10	2017-07-10	Pharyngeal or buccal cavity rinse and process of use thereof

Country Status (4)

Country	Link
EP (1)	EP3651731A4 (en)
AU (1)	AU2017423488A1 (en)
CA (1)	CA3067644A1 (en)
WO (1)	WO2019013750A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998017195A1 (en) *	1996-10-23	1998-04-30	The Research Foundation Of State University Of New York	COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (Eh) LEVELS
US20050069503A1 (en) *	2003-03-10	2005-03-31	Larsen Robert K.	Tooth whitening mouthwashes and methods for making and using them
US20090123570A1 (en) *	2007-11-09	2009-05-14	Warner W Randolph	Composition and method for treating sore throat
WO2010008318A1 (en) *	2008-07-18	2010-01-21	Odinets Aleksei Glebovich	Antiviral agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5392947A (en) *	1993-10-29	1995-02-28	Chesebrough-Pond's Usa Co., Division Of Conopco, Inc.	Dental mouthwash product
US20100209540A1 (en) *	2008-11-05	2010-08-19	Pharmacaribe	Inhalation formulation for treating and prophylactic use in bacteria, mycobacterial and fungal respiratory infections
KR101450098B1 (en) *	2012-05-04	2014-10-14	동의대학교 산학협력단	Composition for cleaning oral cavity containing fucoidan
US10434119B2 (en) *	2016-01-13	2019-10-08	Gargle Water, Inc.	Pharyngeal or buccal cavity rinse and process of use thereof

2017
- 2017-07-10 CA CA3067644A patent/CA3067644A1/en active Pending
- 2017-07-10 AU AU2017423488A patent/AU2017423488A1/en active Pending
- 2017-07-10 WO PCT/US2017/041365 patent/WO2019013750A1/en unknown
- 2017-07-10 EP EP17917864.5A patent/EP3651731A4/en not_active Withdrawn

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998017195A1 (en) *	1996-10-23	1998-04-30	The Research Foundation Of State University Of New York	COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (Eh) LEVELS
US20050069503A1 (en) *	2003-03-10	2005-03-31	Larsen Robert K.	Tooth whitening mouthwashes and methods for making and using them
US20090123570A1 (en) *	2007-11-09	2009-05-14	Warner W Randolph	Composition and method for treating sore throat
WO2010008318A1 (en) *	2008-07-18	2010-01-21	Odinets Aleksei Glebovich	Antiviral agent

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LEE JUNG-BUM ET AL: "Novel Antiviral Fucoidan from Sporophyll of Undaria pinnatifida (Mekabu)", CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 52, no. 9, 1 September 2004 (2004-09-01), JP, pages 1091 - 1094, XP055839911, ISSN: 0009-2363, DOI: 10.1248/cpb.52.1091 *
RABANAL MELISSA ET AL: "The system of fucoidans from the brown seaweedDictyota dichotoma: Chemical analysis and antiviral activity", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS , LTD BARKING, GB, vol. 101, 14 October 2013 (2013-10-14), pages 804 - 811, XP028790644, ISSN: 0144-8617, DOI: 10.1016/J.CARBPOL.2013.10.019 *
REGINA ELIZONDO-GONZALEZ ET AL: "In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, vol. 9, no. 1, 12 December 2012 (2012-12-12), pages 307, XP021137092, ISSN: 1743-422X, DOI: 10.1186/1743-422X-9-307 *
See also references of WO2019013750A1 *

Also Published As

Publication number	Publication date
CA3067644A1 (en)	2019-01-17
EP3651731A1 (en)	2020-05-20
WO2019013750A1 (en)	2019-01-17
AU2017423488A1 (en)	2020-01-16

Publication	Publication Date	Title
EP3630199A4 (en)	2021-11-10	Oligonucleotide compositions and methods of use thereof
EP3732137A4 (en)	2021-11-03	Microbial-based composition and method of use
EP3630788A4 (en)	2021-04-28	Oligonucleotide compositions and methods of use thereof
EP3630789A4 (en)	2021-06-16	Oligonucleotide compositions and methods of use thereof
EP3652316A4 (en)	2021-04-07	Incorporation of unnatural nucleotides and methods thereof
EP3463381A4 (en)	2020-01-01	Nucleotide derivatives and methods of use thereof
EP3402549A4 (en)	2019-09-11	Microneedle compositions and methods of using same
EP3823775A4 (en)	2022-03-23	Articles and methods of manufacture
EP3694390A4 (en)	2021-06-16	Endoscope and method of use
IL273959A (en)	2020-05-31	Methods and compositions for the treatment of rare diseases
EP3160451A4 (en)	2018-07-04	Buccal and sublingual cannabinoid formulations and method of making the same
EP3426250A4 (en)	2020-05-06	Methods of treatment
EP3551033A4 (en)	2020-07-29	Endoscope and method of use
EP3602606A4 (en)	2020-02-05	Surface treatment methods and compositions therefor
EP3408344A4 (en)	2019-07-10	Well treatment methods and compositions
EP3129024A4 (en)	2017-11-22	Nicotine formulations and methods of making the same
EP3600716A4 (en)	2020-12-09	X-joints and methods of manufacture
GB2547336B (en)	2021-01-13	Resilent unit and method of manufacture
EP3280422A4 (en)	2018-12-05	Compositions and methods for the treatment of hbv infection
EP3436081A4 (en)	2019-07-24	Microrna compositions and methods of making and using same
IL272937A (en)	2020-04-30	Compositions and methods for the treatment of fibrotic diseases
EP3510134A4 (en)	2020-06-24	Cleaning composition, method of making and use thereof
EP3349755A4 (en)	2019-04-24	Nicotine formulations and methods of making and using the same
EP3160299A4 (en)	2018-02-28	Oral care implement and method of manufacturing an oral care implement
EP3485839A4 (en)	2020-03-11	Dental hand piece and method for manufacturing dental hand piece

Legal Events

Date	Code	Title	Description
2019-01-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2020-04-17	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2020-04-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE
2020-05-20	17P	Request for examination filed	Effective date: 20200109
2020-05-20	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2020-05-20	AX	Request for extension of the european patent	Extension state: BA ME
2020-10-14	DAV	Request for validation of the european patent (deleted)
2020-10-14	DAX	Request for extension of the european patent (deleted)
2021-03-10	A4	Supplementary search report drawn up and despatched	Effective date: 20210210
2021-03-10	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 8/58 20060101AFI20210204BHEP Ipc: A61K 8/73 20060101ALI20210204BHEP Ipc: A61K 8/22 20060101ALI20210204BHEP Ipc: A61Q 11/00 20060101ALI20210204BHEP Ipc: A61K 9/08 20060101ALI20210204BHEP Ipc: A61K 47/02 20060101ALI20210204BHEP
2023-06-14	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date: 20230510
2023-06-23	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2023-07-26	17Q	First examination report despatched	Effective date: 20230627
2024-07-19	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2024-08-21	18D	Application deemed to be withdrawn	Effective date: 20240403